Abiraterone (originator and generics) for treating newly diagnosed high-risk hormone‑sensitive metastatic prostate cancer

Evaluation committee members

The highly specialised technologies committee is a standing advisory committee of NICE. This topic was considered as a cost comparison by the chair, vice chair and a lead team of the highly specialised technologies committee.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

Chair

Paul Arundel
Chair, highly specialised technologies evaluation committee

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager and an associate director.

Giacomo De Guisa
Technical lead

Albany Chandler
Technical adviser

Thomas Feist
Project manager

Richard Diaz
Associate director

ISBN: 978-1-4731-7318-7